MedTrace Logo

Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease

NCT02420184 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2022-05-23

No results posted yet for this study

Summary

This study is being conducted to determine whether treatment of obstructive sleep apnea (OSA) in patients with chronic kidney disease (CKD) improves kidney function. Half of the participants will receive continuous positive airway pressure (CPAP) treatment for their OSA in addition to their regular CKD treatment, while the other half will only receive their regular CKD treatment.

Conditions

  • Sleep Apnea, Obstructive
  • Renal Insufficiency, Chronic

Interventions

DEVICE

CPAP

Participants randomized into the experimental CPAP therapy arm will receive CPAP in addition to their standard medical therapy for CKD. CPAP will be worn whenever the participant sleeps for the duration of the study.

OTHER

No CPAP

Participants randomized into the placebo comparator no CPAP arm will receive standard medical therapy for CKD.

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Patrick J Hanly, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02420184 on ClinicalTrials.gov